Concepedia

Anna Belcheva

AB

Statistics

Publications

9

Citations

793

H-Index

9

Active since

2005

Affiliations

Methodist Hospital(Current)

Houston Methodist

The University of Texas MD Anderson Cancer Center

The University of Texas at San Antonio Health Science Center

Medical University of Varna

Anna Belcheva is an author at Methodist Hospital specializing in medicine, pharmacology, and molecular oncology.

Publications per year

2005–2021

9

Publications

9

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

Jane Wey, Marya F. McCarty, Anna Belcheva et al. · Oncogene · 2005 · 343 citations

Medicine, Cancer Biology, Oncology +14

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer

Andrew W. Chung, Kartik Anand, Ann C. Anselme et al. · Science Translational Medicine · 2021 · 109 citations

Medicine, Oncology, Pharmacology +10

Current knowledge of Aronia melanocarpa as a medicinal plant.

Stefka Valcheva-Kuzmanova, Anna Belcheva · PubMed · 2006 · 97 citations

Life Sciences, Botany, Pharmacology +15

Neuropilin-1 Suppresses Tumorigenic Properties in a Human Pancreatic Adenocarcinoma Cell Line Lacking Neuropilin-1 Coreceptors

Michael J. Gray, Jane Wey, Anna Belcheva et al. · Cancer Research · 2005 · 80 citations · Full text

Medicine, Cancer Biology, Oncology +13

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

Tejal Patel, Sarah L. Creamer, Toniva Boone et al. · Breast Cancer Research · 2019 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 9